Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
about
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2Kinase inhibitors from marine spongesReactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosisAccelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2.Disruption of histone modification and CARM1 recruitment by arsenic represses transcription at glucocorticoid receptor-regulated promoters.Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1.Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide.Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλ signalingArsenic inhibits SGK1 activation of CFTR Cl- channels in the gill of killifish, Fundulus heteroclitus.Environmental epigenetics in metal exposure.Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-κB-dependent genesAutophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxideRole of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis.Regulation of the kinase RSK1 by arsenic trioxide and generation of antileukemic responsesRole of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responsesBiological responses to arsenic compoundsDevelopment of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine.Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.Influence of Arsenic on Global Levels of Histone Posttranslational Modifications: a Review of the Literature and Challenges in the FieldMSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma.Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursors.Activation of protein kinase C{eta} by type I interferonsPotentiation of arsenic neurotoxicity by folate deprivation: protective role of S-adenosyl methionine.p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death.Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.Mitogen- and Stress-Activated Protein Kinase 1 Regulates Status Epilepticus-Evoked Cell Death in the Hippocampus.Mitogen-activated protein kinase Hog1 mediates adaptation to G1 checkpoint arrest during arsenite and hyperosmotic stress.Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
P2860
Q24317497-B1B0B82D-FFC8-4171-A4F0-C139A1832599Q26864357-AA92802B-BD1D-45B1-9E88-F710E5B068EFQ28388476-3B56A8F7-514B-470C-876C-277E6E5BD7BAQ30315937-2B7CCA0B-F6D8-4796-A160-6CC9D3C43CB4Q33496730-D9A37C66-778A-4864-AA13-AEE0DD242BB3Q33862077-8A0ECD00-EB8D-4EAF-A065-314476FAD2CFQ34144553-F1E618B4-DF6A-408A-9A96-4653968C72EFQ34310053-785A351C-3DF3-4B92-BF3E-9CAE2155AFD1Q34401177-7AA296D6-AA75-40BB-8BE1-1789B973AC2FQ34488887-268BC182-094D-4D47-BC69-05A770FD83D1Q34705868-9C6C04C5-D817-42FB-9666-8836D9996FC4Q35592179-11DEA6F7-D8A1-4C23-84BF-95DC1A284EB1Q35721648-6E31A9EC-31B7-42ED-9B8E-B4AD0925D622Q36352545-367BE473-C493-4C59-A9E4-2FE2292660F8Q36724764-F620C41B-4A7F-4006-882A-8EE118D3B4D9Q36901497-D7FFB8CC-DF91-4905-B22F-A2EBA436F1CEQ37375719-5C32FC47-9320-4FBF-9D51-CA330BCBFA6FQ37442397-F315E8AF-0917-4861-A383-83709695DD2AQ37570454-52A006F5-7604-4597-8789-B9D507A7EF6CQ37692470-76387ADC-6AEB-4F41-BFC5-86568B429D97Q38761300-FD561C4D-05C2-49D9-8E74-6DDC1B896457Q38769933-94B6754F-27F0-401E-AEF0-46F855ED9372Q38923281-DC9A3BEB-FB3D-487D-9DA5-10C05AF2045CQ38945222-0D4FDFCF-0181-4B60-9C82-1CBC53267779Q39884881-929FCC5A-6BBD-457B-9DF6-4BD141C76ECCQ40011614-94D8BAA0-4855-4617-B164-ADB367F80236Q40116611-0641603E-0300-4DBC-B025-4FE5EE57494CQ40134056-E35AA519-7713-4EA1-A26E-19E22BEF3532Q41587748-6A55E43B-2B5D-4BF9-A4CB-81CA5553A619Q42003030-4F30CF5A-4E63-4E02-B48A-65560F52E277Q46874668-121F87B6-C71A-4FCF-B16C-7AFB880E29B3Q47435333-6743E215-6242-48DF-A717-1D49AC219163
P2860
Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
@en
type
label
Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
@en
prefLabel
Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
@en
P2093
P2860
P356
P1476
Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide.
@en
P2093
Efstratios Katsoulidis
J Simon C Arthur
Leonidas C Platanias
Padma Kannan-Thulasiraman
P2860
P304
22446-22452
P356
10.1074/JBC.M603111200
P407
P577
2006-06-08T00:00:00Z